4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Quoin Pharmaceuticals, Ltd. (QNRX) operates in the Biotechnology industry and is headquartered in Ashburn, United States with about 4 employees. Its market capitalization is roughly $15 million. In the fiscal year ended 2025-12-31, QNRX reported $0M in revenue and ($16M) in net income.
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($16M) | ($10M) | ($9M) | ($9M) | — |
| Net Income | ($16M) | ($9M) | ($9M) | ($9M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($6M) | ($5M) | ($4M) | ($4M) | ($4M) |
| Net Income | ($5M) | ($5M) | ($4M) | ($4M) | ($4M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $20M | $16M | $12M | $14M | — |
| Total Liabilities | $7M | $6M | $6M | $7M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive QNRX viewer.
About TickerBase · Data methodology & sources · Privacy · Terms